Clinical Trials for Nuvalent

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Nuvalent

Clinical Trials (4)

NCT06765109
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
PHASE3Recruiting
450 participants
Started: Jul 17, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor32 locations
NCT06521554
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
PHASE1Recruiting
150 participants
Started: Jul 18, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor21 locations
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
PHASE1/PHASE2Recruiting
840 participants
Started: Jun 9, 2022 · Completed: Jan 31, 2028
2 conditions1 sponsor74 locations
NCT05118789
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
PHASE1/PHASE2Recruiting
359 participants
Started: Jan 4, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor63 locations